Intersuisse

Intersuisse is an Australian financial services and corporate advisory firm that has historically played a significant role in the growth of the Australian biotechnology and life sciences sector. The company is widely recognized for establishing the Intersuisse Biotechnology Index, a benchmark used to track the performance of listed healthcare and biotech stocks on the Australian Securities Exchange (ASX). Through its specialized division, Intersuisse Bioscience, the firm provides strategic consulting, capital raising, and investment management services tailored to the life sciences industry. In 2007, the corporate advisory arm of Intersuisse transitioned to become part of PhillipCapital Australia, though the Intersuisse name remains synonymous with biotech sector analysis and investment in the region. The firm has acted as a key intermediary, facilitating international collaborations and providing critical market intelligence for the Australian life sciences ecosystem.